A representative prescription for emotional disease, Ding-Zhi-Xiao-Wan restores 5-HT system deficit through interfering the synthesis and transshipment in chronic mild stress-induced depressive rats
- PMID: 24184266
- DOI: 10.1016/j.jep.2013.10.018
A representative prescription for emotional disease, Ding-Zhi-Xiao-Wan restores 5-HT system deficit through interfering the synthesis and transshipment in chronic mild stress-induced depressive rats
Abstract
Ethnopharmacological relevance: Ding-Zhi-Xiao-Wan (DZ, also known as Kai-Xin-San) is a famous traditional Chinese medicine used for the treatment of emotional disease. Previously, we have found that in a variety of animal models of depression (such as tail suspension model, model of chronic fatigue and forced swimming model) DZ demonstrated significant antidepressant behavior and promoted the production of 5-hydroxytryptamine (5-HT). However, the mechanisms of 5-HT regulation are still unclear. Therefore, the current study is designed to further investigate the antidepressant effect of DZ by observing its influence on 5-HT synthesis, metabolism, transport and other key links, so as to clarify the molecular mechanism of its 5-HT regulation.
Materials and methods: Solitary rising combined with the chronic unpredictable mild stress (CMS) was used to establish the rat model of depression. The rats were given DZ for 3 weeks, the behavior change and the following items in hippocampus and prefrontal cortex were detected simultaneously: 5-HT, 5-hydroxyindoleacetic acid (5-HIAA), tryptophan hydroxylase (TPH), aromatic amino acid decarboxylase (AADC), monoamine oxidase (MAO) and 5-HT transporter (5-HTT) were observed.
Results: Our results showed that treatment with the DZ significantly improved the behavior and simultaneously increased the 5-HT level in the hippocampus, prefrontal cortex tissues and hippocampus extracellular of depressive rats. In future studies revealed that DZ could significantly increase the protein and mRNA expression of the key enzymes TPH during the 5-HT synthesis process in the hippocampus and prefrontal cortex of the depressed rats, and suppress the expression of 5-HTT protein and mRNA at the same time. But it had no effects on MAO-A and MAO-B activities.
Conclusion: We believe that antidepressant effect of DZ is caused by the increase of 5-HT synthesis and reduction of 5-HT re-uptake, and eventually increase the content of 5-HT in the brain and the synaptic gaps.
Keywords: 5-HT; Depression; Ding-Zhi-Xiao-Wan; Re-uptake; Synthesis.
© 2013 Published by Elsevier Ireland Ltd.
Similar articles
-
[Effect of Rehmanniae Radix on depression-like behavior and hippocampal monoamine neurotransmitters of chronic unpredictable mild stress model rats].Zhongguo Zhong Yao Za Zhi. 2022 Sep;47(17):4691-4697. doi: 10.19540/j.cnki.cjcmm.20220421.401. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 36164876 Chinese.
-
Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.J Ethnopharmacol. 2012 May 7;141(1):257-64. doi: 10.1016/j.jep.2012.02.026. Epub 2012 Feb 17. J Ethnopharmacol. 2012. PMID: 22366432
-
Uncovering pharmacological mechanisms of Zhi-Zi-Hou-Po decoction in chronic unpredictable mild stress induced rats through pharmacokinetics, monoamine neurotransmitter and neurogenesis.J Ethnopharmacol. 2019 Oct 28;243:112079. doi: 10.1016/j.jep.2019.112079. Epub 2019 Jul 11. J Ethnopharmacol. 2019. PMID: 31302206
-
[Dynamic changes of brain serotonergic and dopaminergic activities during development of anxious depression: experimental study].Usp Fiziol Nauk. 2004 Oct-Dec;35(4):19-40. Usp Fiziol Nauk. 2004. PMID: 15573884 Review. Russian.
-
Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Neuropharmacology. 2008. PMID: 18761360 Review.
Cited by
-
MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1.Heliyon. 2023 Mar 7;9(3):e14265. doi: 10.1016/j.heliyon.2023.e14265. eCollection 2023 Mar. Heliyon. 2023. PMID: 36938448 Free PMC article.
-
Systematic review of Kaixinsan in treating depression: Efficacy and pharmacological mechanisms.Front Behav Neurosci. 2022 Dec 6;16:1061877. doi: 10.3389/fnbeh.2022.1061877. eCollection 2022. Front Behav Neurosci. 2022. PMID: 36560929 Free PMC article.
-
KXS Balances the Tryptophan Metabolism in Mild to Moderate Depressed Patients and Chronic Restraint Stress Induced Depressive Rats.Neuropsychiatr Dis Treat. 2022 Nov 1;18:2485-2496. doi: 10.2147/NDT.S377982. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36345420 Free PMC article.
-
Antidepressant Mechanism of Kaixinsan and Its Active Compounds Based on Upregulation of Antioxidant Thioredoxin.Evid Based Complement Alternat Med. 2022 Jul 19;2022:7302442. doi: 10.1155/2022/7302442. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35911169 Free PMC article.
-
Behavioral and Biochemical Effects of KXS on Postmyocardial Infarction Depression.Front Pharmacol. 2020 Aug 27;11:561817. doi: 10.3389/fphar.2020.561817. eCollection 2020. Front Pharmacol. 2020. PMID: 32973539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
